Watchlist Price Alert

Petros Pharmaceuticals In... (PTPI)

NASDAQ: PTPI · Real-Time Price · USD

0.14

-0.02 (-12.50%)

At close: May 16, 2025, 3:59 PM

0.14

2.52%

Pre-market: May 19, 2025, 05:44 AM EDT

Petros Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	3.71M	13.34M	9.43M	23.85M	17.14M	2.15M	2.79M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	4.18M	5.11M	11.03M	11.14M	7.4M	4.53M
Receivables	416.08K	2.23M	2.11M	2.46M	5.15M	2.61M	3.51M
Inventory	1.35M	1.61M	1.82M	519.65K	760.53K	2.2M	6.49M
Other Current Assets	1.66M	816.21K	802.21K	1.53M	1.48M	3.57M	1.64M
Total Current Assets	7.29M	20.39M	14.67M	30.54M	25.91M	12.09M	15.81M
Property-Plant & Equipment	136.68K	255.22K	397.65K	524.95K	643.78K	69.84K	n/a
Goodwill & Intangibles	3.2M	8.97M	12.24M	25.29M	32.16M	38.81M	46.54M
Total Long-Term Assets	3.34M	13.41M	17.75M	36.85M	43.95M	46.28M	51.08M
Total Assets	10.64M	33.8M	32.42M	67.39M	69.85M	58.37M	66.89M
Account Payables	2.33M	1.71M	1.81M	4.56M	5.61M	3.78M	1.75M
Deferred Revenue	1.91M	2.05M	n/a	-125.58K	28.89M	30.19M	n/a
Short-Term Debt	7.25M	1.16M	1.09M	n/a	7.18M	6.68M	19.3M
Other Current Liabilities	8.39M	1.11M	2.71M	22.93M	26.15M	22.63M	12.57M
Total Current Liabilities	18.03M	10.77M	7.07M	30.98M	41.89M	41.1M	38.54M
Long-Term Debt	n/a	6.86M	8.39M	n/a	n/a	7.06M	27.89M
Other Long-Term Liabilities	75.15M	3.55M	1.00	460K	10.49M	109.98K	57.4K
Total Long-Term Liabilities	75.22M	10.55M	8.65M	865.02K	10.49M	9.24M	30.03M
Total Liabilities	18.1M	21.32M	15.72M	31.85M	52.38M	50.35M	68.57M
Total Debt	7.39M	8.28M	9.88M	405.02K	7.18M	13.74M	47.19M
Common Stock	1.05K	298.00	208.00	2.07K	971.00	29.12M	n/a
Retained Earnings	-113.21M	-98.89M	-90.73M	-70.69M	-61.7M	-41.12M	-1.68M
Comprehensive Income	n/a	n/a	n/a	0.00	-0.00	-29.12M	n/a
Shareholders Equity	-7.47M	12.48M	16.7M	35.54M	17.47M	8.02M	-1.68M
Total Investments	3.71B	n/a	n/a	n/a	n/a	n/a	n/a